Tag Archives: retreatment

Time to switch? Switching from innovator rituximab to biosimilar CT-P10 is safe and efficacious

Rituximab is a monoclonal antibody that targets the CD20 protein that is found mainly on immune cells called B lymphocytes. By removing CD20-positive B lymphocytes from the peripheral blood and bone marrow, rituximab provides effective treatment for